BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27420898)

  • 21. TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.
    Nicolau CA; Gavard J; Bidère N
    Cell Immunol; 2020 Jul; 353():104115. PubMed ID: 32388054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.
    Yin H; Karayel O; Chao YY; Seeholzer T; Hamp I; Plettenburg O; Gehring T; Zielinski C; Mann M; Krappmann D
    Cell Mol Life Sci; 2022 Jan; 79(2):112. PubMed ID: 35099607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
    Lu HY; Bauman BM; Arjunaraja S; Dorjbal B; Milner JD; Snow AL; Turvey SE
    Front Immunol; 2018; 9():2078. PubMed ID: 30283440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
    Lork M; Staal J; Beyaert R
    Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-kappaB signaling in lymphocytes: a new cast of characters.
    Lucas PC; McAllister-Lucas LM; Nunez G
    J Cell Sci; 2004 Jan; 117(Pt 1):31-9. PubMed ID: 14657271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation.
    Ginster S; Bardet M; Unterreiner A; Malinverni C; Renner F; Lam S; Freuler F; Gerrits B; Voshol J; Calzascia T; Régnier CH; Renatus M; Nikolay R; Israël L; Bornancin F
    PLoS One; 2017; 12(1):e0169026. PubMed ID: 28052131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
    Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
    J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
    Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
    Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling.
    Douanne T; Gavard J; Bidère N
    J Cell Sci; 2016 May; 129(9):1775-80. PubMed ID: 27006117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation.
    Ishiguro K; Green T; Rapley J; Wachtel H; Giallourakis C; Landry A; Cao Z; Lu N; Takafumi A; Goto H; Daly MJ; Xavier RJ
    Mol Cell Biol; 2006 Jul; 26(14):5497-508. PubMed ID: 16809782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.
    Fontán L; Melnick A
    Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4 ligation excludes the Carma1-Bcl10-MALT1 complex from GM1-positive membrane rafts in CD3/CD28 activated T cells.
    Rigo M; Chentouf M; Pèlegrin A; Chardès T
    Cell Immunol; 2011; 270(1):40-6. PubMed ID: 21489413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
    Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
    Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of NF-κB pathway activation in T helper cells.
    Gorka O; Wanninger S; Ruland J
    Methods Mol Biol; 2014; 1193():69-83. PubMed ID: 25150998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II.
    Ishiguro K; Ando T; Goto H; Xavier R
    Mol Immunol; 2007 Mar; 44(8):2095-100. PubMed ID: 17052756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-translational modifications regulate distinct functions of CARMA1 and BCL10.
    Thome M; Weil R
    Trends Immunol; 2007 Jun; 28(6):281-8. PubMed ID: 17468049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.
    McAuley JR; Freeman TJ; Ekambaram P; Lucas PC; McAllister-Lucas LM
    Front Immunol; 2018; 9():1887. PubMed ID: 30158935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural insights into the assembly of CARMA1 and BCL10.
    Li S; Yang X; Shao J; Shen Y
    PLoS One; 2012; 7(8):e42775. PubMed ID: 22880103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-kappaB activation in T cells requires discrete control of IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation and IKKgamma ubiquitination by the ADAP adapter protein.
    Srivastava R; Burbach BJ; Shimizu Y
    J Biol Chem; 2010 Apr; 285(15):11100-5. PubMed ID: 20164171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
    Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
    Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.